HomeInsightsPE

Thyrocare Technologies Ltd PE Ratio

Thyrocare Technologies Ltd PE Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Thyrocare Technologies Ltd

NSE: THYROCARE

PE

60.4

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Thyrocare Technologies Ltd is 60.4 as of 23 Nov 9.00 AM .
  • The P/E Ratio of Thyrocare Technologies Ltd changed from 32.9 on March 2019 to 44.3 on March 2024 . This represents a CAGR of 5.08% over 6 years.
  • The Latest Trading Price of Thyrocare Technologies Ltd is ₹ 957.45 as of 22 Nov 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 47.6 to 43.3 in 5 years. This represents a CAGR of -1.88%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 63.4. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Thyrocare Technologies Ltd

No data available

Company Fundamentals for Thyrocare Technologies Ltd

No data available

Image

Thyrocare Technologies Ltd

NSE: THYROCARE

Share Price

₹ 957.45

-12.90 (-1.33%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Thyrocare Technologies Ltd

1M

1Y

3Y

5Y

Monitoring Thyrocare Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024957.45
21 Nov 2024970.35
19 Nov 2024964.7
18 Nov 2024982.95
14 Nov 2024976.4
13 Nov 2024947.85
12 Nov 2024961.9
11 Nov 2024984.4
08 Nov 2024980.05
07 Nov 2024966.45

SWOT Analysis Of Thyrocare Technologies Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Thyrocare Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Thyrocare Technologies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Thyrocare Technologies Ltd

No data available

No data available

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical Revenue of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical EBITDA of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical Net Profit of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical Dividend Payout of Thyrocare Technologies Ltd

No data available

* All values are in %

About Thyrocare Technologies Ltd

  • Thyrocare Technologies Limited was incorporated in January, 2000.
  • The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
  • Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
  • The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).

Thyrocare Technologies Ltd News Hub

News

Thyrocare Technologies AGM scheduled

Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will...

Read more

2024-08-06 00:00:00

News

Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the l...

Read more

2024-08-30 00:00:00

News

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagno...

Read more

2024-08-30 00:00:00

News

Thyrocare Technologies announces cessation of director

Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 0262236...

Read more

2024-09-19 00:00:00

News

Thyrocare Technologies schedules board meeting

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

2024-10-17 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Thyrocare Technologies Ltd

What is the current PE Ratio of Thyrocare Technologies Ltd?

The Current PE Ratio of Thyrocare Technologies Ltd is 60.41 as on 23 Nov 2024.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 63.4 as on 23 Nov 2024.

What was the PE Ratio of Thyrocare Technologies Ltd last year?

The PE Ratio of Thyrocare Technologies Ltd was 35.28 last year, now the PE ratio is 60.41, showing a year-on-year growth of 71.2%.

What does the PE Ratio of Thyrocare Technologies Ltd indicate about its stock?

The PE Ratio of Thyrocare Technologies Ltd is 60.41. This ratio indicates that investors are willing to pay 60.41 times the earnings per share for each share of Thyrocare Technologies Ltd.

What is the PE Ratio Growth of Thyrocare Technologies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Thyrocare Technologies Ltd grew by 71.2% whereas, the EPS ratio grew by 10.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*